• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Pharma

JNJ
Pharma

J&J innovative medicine chief Jennifer Taubert to retire

J&J has named Tom Cavanaugh as the new leader of its innovative medicines business, beginning Sept. 1, 2026.
Angus Liu Aug 4, 2026 10:55am
Bayer Bill Anderson

Bayer CEO Anderson sticking out firm's revitalization scheme

Aug 4, 2026 10:40am
lifesciencetoplinepodcastheroimagenoblepng

Inside Noble’s connected approach to patient support

Brought to you by NOBLE, Inc
Silhouettes of women with different skin colors

Fiercest Women in Life Sciences 2026: Nominations open now

Aug 4, 2026 10:00am
Why the Real Risk in Hub Transition is Inertia

What Hub Transitions Really Cost Manufacturers

Brought to you by Gifthealth
Jazz and PharmaMar Zepzelca for small cell lung cancer

Jazz to withdraw Zepzelca in second-line small cell lung cancer

Aug 4, 2026 9:18am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings